Skip to content

A multicenter randomized controlled study on the treatment of cervical spondylotic radiculopathy with Duyiwei capsules

A multicenter randomized controlled study on the treatment of cervical spondylotic radiculopathy with Duyiwei capsules

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080418
Enrollment
Unknown
Registered
2024-01-29
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylotic radiculopathy

Interventions

Sponsors

Wangjing Hospital of the Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of Western and Traditional Chinese Medicine for cervical spondylotic radiculopathy; (2) Age range from 30 to 70 years old; (3) VAS score = 4 and<7; (4) If other conservative treatments have been received and a washout period of more than 5 days has passed; (5) Sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria; (2) Patients with combined cervical tumors, tuberculosis, osteomyelitis, and severe osteoporosis; (3) Those with severe pain and persistent worsening of root symptoms who meet the surgical indications; (4) Individuals with severe heart, lung, brain, and blood system diseases; (5) Patients with cervical spondylosis other than radiculopathy; (6) Individuals with severe allergic constitution or allergic to the drugs used in this study; (7) Pregnant or lactating women; (8) Individuals with mental illness or other reasons who do not cooperate. (9) Individuals with active peptic ulcers\bleeding, or previous recurrent ulcers\bleeding.

Design outcomes

Primary

MeasureTime frame
Visual analogue pain score;Neck Disability Index table;

Secondary

MeasureTime frame
Adverse Event, AE;Safety index;

Countries

china

Contacts

Public ContactYu Jie

Wangjing Hospital of the Chinese Academy of Traditional Chinese Medicine

doctoryujie@aliyun.com+86 133 6611 3469

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026